We are live on ! Find out more
USNA icon

Usana Health Sciences

188 hedge funds and large institutions have $1.13B invested in Usana Health Sciences in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 62 increasing their positions, 71 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

1% more capital invested

Capital invested by funds: $1.12B → $1.13B (+$12.6M)

0.49% less ownership

Funds ownership: 55.29%54.8% (-0.49%)

5% less funds holding

Funds holding: 198188 (-10)

13% less repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 71

36% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 25

53% less call options, than puts

Call options by funds: $614K | Put options by funds: $1.31M

Holders
188
Holders Change
-10
Holders Change %
-5.05%
% of All Funds
3.27%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
16
Increased
62
Reduced
71
Closed
25
Calls
$614K
Puts
$1.31M
Net Calls
-$697K
Net Calls Change
-$259K
Name Holding Trade Value Shares
Change
Change in
Stake
Hotchkis & Wiley Capital Management
26
Hotchkis & Wiley Capital Management
California
$7.06M +$341K +3,400 +5%
Ameriprise
27
Ameriprise
Minnesota
$6.32M -$268K -2,673 -4%
Wells Fargo
28
Wells Fargo
California
$6.22M -$3.13M -31,215 -34%
HA
29
Heartland Advisors
Wisconsin
$6.15M +$1M +10,000 +20%
Two Sigma Advisers
30
Two Sigma Advisers
New York
$5.99M +$622K +6,200 +12%
PPA
31
Parametric Portfolio Associates
Washington
$5.48M +$360K +3,590 +7%
SEI Investments
32
SEI Investments
Pennsylvania
$5.39M +$528K +5,256 +11%
AllianceBernstein
33
AllianceBernstein
Tennessee
$4.96M +$198K +1,970 +4%
UBS Group
34
UBS Group
Switzerland
$4.45M -$1.07M -10,669 -20%
CEI
35
Clark Estates Inc
New York
$4.25M
Robeco Institutional Asset Management
36
Robeco Institutional Asset Management
Netherlands
$4.23M -$434K -4,322 -9%
Jacobs Levy Equity Management
37
Jacobs Levy Equity Management
New Jersey
$4.19M -$205K -2,039 -5%
BA
38
Bridgewater Associates
Connecticut
$3.74M +$3.67M +36,530 New
Two Sigma Investments
39
Two Sigma Investments
New York
$3.74M +$1.49M +14,883 +69%
AQR Capital Management
40
AQR Capital Management
Connecticut
$3.47M -$926K -9,219 -21%
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$3.46M -$71.9K -716 -2%
First Trust Advisors
42
First Trust Advisors
Illinois
$3.3M +$1.88M +18,773 +139%
Legal & General Group
43
Legal & General Group
United Kingdom
$3.29M -$867K -8,635 -21%
Assenagon Asset Management
44
Assenagon Asset Management
Luxembourg
$3.03M -$3.94M -39,198 -57%
TD Asset Management
45
TD Asset Management
Ontario, Canada
$2.85M +$141K +1,400 +5%
Swiss National Bank
46
Swiss National Bank
Switzerland
$2.85M -$110K -1,100 -4%
American Century Companies
47
American Century Companies
Missouri
$2.72M -$333K -3,315 -11%
PGCM
48
Prescott Group Capital Management
Oklahoma
$2.66M
ETM
49
Euclidean Technologies Management
Washington
$2.6M +$46.1K +459 +2%
WG
50
Winton Group
United Kingdom
$2.6M +$210K +2,088 +9%

USNA Hedge Fund Activity: Q2 2021 in Review

188 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q2 2021, worth a combined $1.13B — up 1.1% from $1.12B a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of USNA and 16 opened new positions — a net loss of 9 holders — while 71 trimmed existing stakes and 62 added.

The largest buyer was Invesco, adding an estimated $10M. The largest seller was CAAS Capital Management, exiting entirely with an estimated $13.8M sold.

  • 188 institutional investors held Usana Health Sciences (USNA) as of Q2 2021, down from 198 in Q1 2021.
  • Funds reported $1.13B of Usana Health Sciences stock for Q2 2021, up 1.1% quarter-over-quarter.
  • 16 funds opened new Usana Health Sciences positions in Q2 2021 and 25 closed out, a net change of -9 holders.
  • The largest Usana Health Sciences buyer in Q2 2021 was Invesco, an estimated $10M added.
  • The largest Usana Health Sciences seller in Q2 2021 was CAAS Capital Management, an estimated $13.8M sold.

Based on aggregated 13F filings for Q2 2021.